Gene · 5734
Papers4,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between vertebral endplate defects and patient-reported symptoms: an immunohistochemical study investigating the COX-2/PGE-2/EP-4 axis. | Spine J | 2024 | 38631491 | PubTator, text mining | PubMed |
| Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC. | BMC Cancer | 2024 | 38605343 | PubTator, text mining | PubMed |
| Disruption of epithelium integrity by inflammation-associated fibroblasts through prostaglandin signaling. | Sci Adv | 2024 | 38569041 | PubTator, text mining | PubMed |
| Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non-small-cell lung cancer. | Clin Transl Med | 2024 | 38445456 | PubTator, text mining | PubMed |
| Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade. | J Transl Med | 2024 | 38443917 | PubTator, text mining | PubMed |
| Exploring miRNA‑target gene profiles associated with drug resistance in patients with breast cancer receiving neoadjuvant chemotherapy. | Oncol Lett | 2024 | 38426156 | PubTator, text mining | PubMed |
| Pharmacological evidence that the inhibitory effects of prostaglandin E2 are mediated by the EP2 and EP4 receptors in human neutrophils. | J Leukoc Biol | 2024 | 38345417 | PubTator, text mining | PubMed |
| EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells. | Front Immunol | 2024 | 38343540 | PubTator, text mining | PubMed |
| The signature of cancer methylation markers in maternal plasma: Factors influencing the development and application of cancer liquid biopsy assay. | Gene | 2024 | 38342253 | PubTator, text mining | PubMed |
| Dynamic Boolean modeling of molecular and cellular interactions in psoriasis predicts drug target candidates. | iScience | 2024 | 38303723 | PubTator, text mining | PubMed |
| VentX promotes tumor specific immunity and efficacy of immune checkpoint inhibitors. | iScience | 2024 | 38299030 | PubTator, text mining | PubMed |
| Causal relationship between inflammatory bowel disease and erythema nodosum: A two-sample bidirectional Mendelian randomization study. | Skin Res Technol | 2024 | 38297958 | PubTator, text mining | PubMed |
| Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting. | Genes Dis | 2024 | 38292177 | PubTator, text mining | PubMed |
| Chemically-defined and scalable culture system for intestinal stem cells derived from human intestinal organoids. | Nat Commun | 2024 | 38280855 | PubTator, text mining | PubMed |
| Articular cartilage repair biomaterials: strategies and applications. | Mater Today Bio | 2024 | 38269053 | PubTator, text mining | PubMed |
| Herpesviridae, Neurodegenerative Disorders and Autoimmune Diseases: What Is the Relationship between Them? | Viruses | 2024 | 38257833 | PubTator, text mining | PubMed |
| Silica Nanoparticles Shed Light on Intriguing Cellular Pathways in Human Tracheal Smooth Muscle Cells: Revealing COX-2/PGE2 Production through the EGFR/Pyk2 Signaling Axis. | Biomedicines | 2024 | 38255212 | PubTator, text mining | PubMed |
| Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs. | Exp Hematol Oncol | 2024 | 38254219 | PubTator, text mining | PubMed |
| The implications for urological malignancies of non-coding RNAs in the the tumor microenvironment. | Comput Struct Biotechnol J | 2024 | 38249783 | PubTator, text mining | PubMed |
| Plasma Cell-Free Tumor Methylome as a Biomarker in Solid Tumors: Biology and Applications. | Curr Oncol | 2024 | 38248118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5734/papers?page=12